Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: Utilization of clinical data when patients applied to receive public financial aid

Journal of Epidemiology

Volumn 17, Issue 6, 2007, Pages 210-214

  Sakauchi, Fumio ^a   Oura, Asae ^a   Ohnishi, Hirofumi ^a   Mori, Mitsuru ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimitochondrial antibodies; Biliary; Clinical findings; Laboratory findings; Liver cirrhosis; Public financial aid

Indexed keywords

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; FEMALE; HUMAN; JAPAN; LIVER FUNCTION TEST; MALE; MIDDLE AGED; SOCIAL CARE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PUBLIC ASSISTANCE;

EID: 37649013600     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.17.210     Document Type: Article

References (20)

1. Lindor KD. Primary biliary cirrhosis. In: Feldman M, Scharschmidt BF, and Sleisenger MH, eds. Sleisenger and Fordrant's gastrointestinal and liver disease: pathology/diagnosis/management. 6th ed. Philadelphia: W. B. Saunders Company; 1998:1275-83.
2. Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M, et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of factors of stage progression in asymptomatic PBC (a-PBC). Hepatology Research 2002; 22: 250-60.
3. Lindor KD, Dickson ER. Primary biliary cirrhosis. In: Schiff ER, Sorrel MF, and Maddrey WC, eds. Schiff's diseases of the liver, 8th ed. Philadelphia: Lippincott-Raven Publishers; 1999:679-92.
4. Uibo R, Salupere V. The epidemiology of primary biliary cirrhosis: immunological problems. Hepato-Gastroenterology 1999; 46: 3048-52.
5. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000; 119: 1631-6.
6. Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2005; 15: 24-8.
7. Sasaki H, Inoue K, Higuchi K, Yasuyama T, Koyata H, Kuroki T, et al. Primary biliary cirrhosis in Japan: national survey by the Subcommittee on Autoimmune hepatitis. Gastroenterol Jpn 1985; 20: 476-85.
8. Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuch K, et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15: 70-7.
9. Kaplan MM. Primary biliary cirrhosis. In: Schiff L, and Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia: J. B. Lippincott Company; 1993:377-410.
10. Sherlock S, Heathcote J. Primary biliary cirrhosis. In: Bircher J, Benhamou JP, McIntyre N, Rizetto M, and Rodés J, eds. Oxford textbook of clinical hepatology. 2nd ed. Oxford University Press; 1999: 1089-98.
11. Sherlock S, Dooley J. Primary biliary cirrhosis. In: Diseases of the liver and biliary system. 11th ed. Blackwell Science; 2002:241-53.
12. Shibazaki S, Nagai M, Asou E, Nakamura Y, Yanagawa H, Kawamura T, et al. Survey of patients with intractable diseases. Analyses of patients receiving financial aid for treatment. Jpn J Public Health 1997; 44: 33-46. (in Japanese)
13. Fuchigami H, Nishina M, Shibazaki S, Nagai M, Kawamura T, Ohono Y. Nationwide survey of intractable disease patients. Analyses of patients receiving public financial aid for treatment in fiscal year 1997. Jpn J Public Health 2002; 49: 774-89. (in Japanese)
14. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chretien Y, Poupon RE, et al. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int 2004; 24: 187-93.
15. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
16. Shi J, Wu C, Lin Y, Chen YX, Zhu L, Xie Wf. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gatroenterol 2006; 101: 1529-38.
17. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmume cholangitis. Gut 1994; 35: 260-5.
18. Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995; 34: 496-501.
19. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-8.
20. Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to rereive public financial aid. J Epidemiol 2006; 16: 30-4.